Hepatocyte-specific hypoxia-inducible factor-1α is a determinant of lipid accumulation and liver injury in alcohol-induced steatosis in mice
- PMID: 21520168
- PMCID: PMC3104403
- DOI: 10.1002/hep.24256
Hepatocyte-specific hypoxia-inducible factor-1α is a determinant of lipid accumulation and liver injury in alcohol-induced steatosis in mice
Abstract
Chronic alcohol causes hepatic steatosis and liver hypoxia. Hypoxia-regulated hypoxia-inducible factor 1-α, (HIF-1α) may regulate liporegulatory genes, but the relationship of HIF-1 to steatosis remains unknown. We investigated HIF-1α in alcohol-induced hepatic lipid accumulation. Alcohol administration resulted in steatosis, increased liver triglyceride levels, and increased serum alanine aminotransferase (ALT) levels, suggesting liver injury in wild-type (WT) mice. There was increased hepatic HIF-1α messenger RNA (mRNA), protein, and DNA-binding activity in alcohol-fed mice compared with controls. Mice engineered with hepatocyte-specific HIF-1 activation (HIF1dPA) had increased HIF-1α mRNA, protein, and DNA-binding activity, and alcohol feeding in HIF1dPA mice increased hepatomegaly and hepatic triglyceride compared with WT mice. In contrast, hepatocyte-specific deletion of HIF-1α [HIF-1α(Hep(-/-) )], protected mice from alcohol- and lipopolysaccharide (LPS)-induced liver damage, serum ALT elevation, hepatomegaly, and lipid accumulation. HIF-1α(Hep(-/-) ), WT, and HIF1dPA mice had equally suppressed levels of peroxisome proliferator-activated receptor α mRNA after chronic ethanol, whereas the HIF target, adipocyte differentiation-related protein, was up-regulated in WT mice but not HIF-1α(Hep(-/-) ) ethanol-fed/LPS-challenged mice. The chemokine monocyte chemoattractant protein-1 (MCP-1) was cooperatively induced by alcohol feeding and LPS in WT but not HIF-1α(Hep(-/-) ) mice. Using Huh7 hepatoma cells in vitro, we found that MCP-1 treatment induced lipid accumulation and increased HIF-1α protein expression as well as DNA-binding activity. Small interfering RNA inhibition of HIF-1α prevented MCP-1-induced lipid accumulation, suggesting a mechanistic role for HIF-1α in hepatocyte lipid accumulation.
Conclusion: Alcohol feeding results in lipid accumulation in hepatocytes involving HIF-1α activation. The alcohol-induced chemokine MCP-1 triggers lipid accumulation in hepatocytes via HIF-1α activation, suggesting a mechanistic link between inflammation and hepatic steatosis in alcoholic liver disease.
Copyright © 2011 American Association for the Study of Liver Diseases.
Figures
Similar articles
-
The role of hypoxia-inducible factor 1α in hepatic lipid metabolism.J Mol Med (Berl). 2023 May;101(5):487-500. doi: 10.1007/s00109-023-02308-5. Epub 2023 Mar 28. J Mol Med (Berl). 2023. PMID: 36973503 Review.
-
Nrf2 Activation Is Required for Ligustrazine to Inhibit Hepatic Steatosis in Alcohol-Preferring Mice and Hepatocytes.Toxicol Sci. 2017 Feb;155(2):432-443. doi: 10.1093/toxsci/kfw228. Epub 2016 Nov 11. Toxicol Sci. 2017. PMID: 27837167
-
HIF-1α induction suppresses excessive lipid accumulation in alcoholic fatty liver in mice.J Hepatol. 2012 Feb;56(2):441-7. doi: 10.1016/j.jhep.2011.07.024. Epub 2011 Sep 5. J Hepatol. 2012. PMID: 21896344
-
An essential role for monocyte chemoattractant protein-1 in alcoholic liver injury: regulation of proinflammatory cytokines and hepatic steatosis in mice.Hepatology. 2011 Dec;54(6):2185-97. doi: 10.1002/hep.24599. Hepatology. 2011. PMID: 21826694 Free PMC article.
-
Alcohol-induced modulation of signaling pathways in liver parenchymal and nonparenchymal cells: implications for immunity.Semin Liver Dis. 2009 May;29(2):166-77. doi: 10.1055/s-0029-1214372. Epub 2009 Apr 22. Semin Liver Dis. 2009. PMID: 19387916 Review.
Cited by
-
Dimethyloxalylglycine Suppresses SREBP1c and Lipogenic Gene Expressions in Hepatocytes Independently of HIF1A.Curr Issues Mol Biol. 2024 Mar 13;46(3):2386-2397. doi: 10.3390/cimb46030151. Curr Issues Mol Biol. 2024. PMID: 38534767 Free PMC article.
-
TXNIP in liver sinusoidal endothelial cells ameliorates alcohol-associated liver disease via nitric oxide production.Int J Biol Sci. 2024 Jan 1;20(2):606-620. doi: 10.7150/ijbs.90781. eCollection 2024. Int J Biol Sci. 2024. PMID: 38169654 Free PMC article.
-
A novel HIF2A mutation causes dyslipidemia and promotes hepatic lipid accumulation.Pharmacol Res. 2023 Aug;194:106851. doi: 10.1016/j.phrs.2023.106851. Epub 2023 Jul 13. Pharmacol Res. 2023. PMID: 37453673
-
Pathogenic mechanisms and regulatory factors involved in alcoholic liver disease.J Transl Med. 2023 May 4;21(1):300. doi: 10.1186/s12967-023-04166-8. J Transl Med. 2023. PMID: 37143126 Free PMC article. Review.
-
Contribution of HIF-1α/BNIP3-mediated autophagy to lipid accumulation during irinotecan-induced liver injury.Sci Rep. 2023 Apr 21;13(1):6528. doi: 10.1038/s41598-023-33848-y. Sci Rep. 2023. PMID: 37085612 Free PMC article.
References
-
- Nath B, Szabo G. Alcohol-induced modulation of signaling pathways in liver parenchymal and nonparenchymal cells: implications for immunity. Semin Liver Dis. 2009;29(2):166–77. - PubMed
-
- Tomita K, et al. Pioglitazone prevents alcohol-induced fatty liver in rats through up-regulation of c-Met. Gastroenterology. 2004;126(3):873–85. - PubMed
-
- Lu Y, et al. Cytochrome P450 2E1 contributes to ethanol-induced fatty liver in mice. Hepatology (Baltimore, Md) 2008;47(5):1483. - PubMed
-
- Lieber CS, et al. Effect of chronic alcohol consumption on Hepatic SIRT1 and PGC-1alpha in rats. Biochem Biophys Res Commun. 2008;370(1):44–8. - PubMed
-
- You M, et al. Ethanol induces fatty acid synthesis pathways by activation of sterol regulatory element-binding protein (SREBP) J Biol Chem. 2002;277(32):29342–7. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous